These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26683595)

  • 1. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
    Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
    Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.
    Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR
    Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.
    Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F
    EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
    Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
    Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
    Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
    J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis
    Zou Y; Lin J; Liu J; Zhang F; Yang T; Gong J; Jiang T; Zuo J; Song R; Shen H; Shen F; Li J
    Curr Protein Pept Sci; 2023; 24(5):436-446. PubMed ID: 37132101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
    Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR
    Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
    Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
    J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
    Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
    Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma.
    Chua HH; Tsuei DJ; Lee PH; Jeng YM; Lu J; Wu JF; Su DS; Chen YH; Chien CS; Kao PC; Lee CN; Hu RH; Ni YH; Chang MH
    Hepatology; 2015 Nov; 62(5):1480-96. PubMed ID: 26185016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
    Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
    PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
    Liu M; Chen L; Chan TH; Wang J; Li Y; Li Y; Zeng TT; Yuan YF; Guan XY
    Hepatology; 2012 Jun; 55(6):1754-65. PubMed ID: 22262416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.
    Song CL; Tang H; Ran LK; Ko BC; Zhang ZZ; Chen X; Ren JH; Tao NN; Li WY; Huang AL; Chen J
    Oncogene; 2016 Feb; 35(5):631-41. PubMed ID: 25915842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling.
    Chen J; Chan AW; To KF; Chen W; Zhang Z; Ren J; Song C; Cheung YS; Lai PB; Cheng SH; Ng MH; Huang A; Ko BC
    Hepatology; 2013 Jun; 57(6):2287-98. PubMed ID: 23348706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.